Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Anne B, Taegtmeyer"'
Autor:
Anne B. Taegtmeyer
Publikováno v:
McGill Journal of Medicine, Vol 10, Iss 1 (2020)
N/A
Externí odkaz:
https://doaj.org/article/f87dc889d5cb4824b5e350d3ba74e0b0
Autor:
Sarah P. Blagden, Johann S. de Bono, Richard Wilson, Mohammed M. Dar, Thomas A. Lampkin, Sharon C. Murray, Deborah A. Smith, Alicia J. Allred, Yan Y. Degenhardt, Hanine Medani, Jorge Barriuso, Anne B. Taegtmeyer, Timothy A. Yap, Andre T. Brunetto, Rohini Sharma, Douglas Barker, David Olmos
Supplementary Methods; Supplementary Table S1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa656e44c9db5425b374f6954cb9ce23
https://doi.org/10.1158/1078-0432.22441227
https://doi.org/10.1158/1078-0432.22441227
Autor:
Sarah P. Blagden, Johann S. de Bono, Richard Wilson, Mohammed M. Dar, Thomas A. Lampkin, Sharon C. Murray, Deborah A. Smith, Alicia J. Allred, Yan Y. Degenhardt, Hanine Medani, Jorge Barriuso, Anne B. Taegtmeyer, Timothy A. Yap, Andre T. Brunetto, Rohini Sharma, Douglas Barker, David Olmos
Purpose: GSK461364 is an ATP-competitive inhibitor of polo-like kinase 1 (Plk1). A phase I study of two schedules of intravenous GSK461364 was conducted.Experimental Design: GSK461364 was administered in escalating doses to patients with solid malign
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ff23bf4b14372b8aa854f554ab505b1
https://doi.org/10.1158/1078-0432.c.6518349
https://doi.org/10.1158/1078-0432.c.6518349
Autor:
Alessandro Ceschi, Elja Heistermann, Sonja Gros, Cornelia Reichert, Hugo Kupferschmidt, Nicholas R Banner, Stephan Krähenbühl, Anne B Taegtmeyer
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0128033 (2015)
There are few data relating to sirolimus overdose in the medical literature. Our objectives were to describe all cases of overdose with sirolimus reported to Swiss, German and Austrian Poisons Centres between 2002-2013.An observational case-series an
Externí odkaz:
https://doaj.org/article/8210ceb6616944d2a43933be2626085a
Autor:
Claudia Gregoriano, Alessandro Ceschi, Christine Rauber-Lüthy, Hugo Kupferschmidt, Nicholas R Banner, Stephan Krähenbühl, Anne B Taegtmeyer
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e86390 (2014)
Literature regarding acute human toxicity of thiopurines is limited to a handful of case reports. Our objectives were to describe all cases of overdose with thiopurines reported to the Swiss Toxicological Information Centre between 1995-2013. A retro
Externí odkaz:
https://doaj.org/article/f2bacf81de264d5cb6edb3343f9516de
Autor:
Anne B Taegtmeyer, Manuel Haschke, Lydia Tchambaz, Mirabel Buylaert, Martin Tschöpl, Ulrich Beuers, Jürgen Drewe, Stephan Krähenbühl
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e97885 (2014)
The main objectives of the study were to determine the exposure and bioavailability of oral propranolol and to investigate their associations with serum bile acid concentration in patients with liver cirrhosis and in healthy controls. A further objec
Externí odkaz:
https://doaj.org/article/d344c99efa9b4fd6b57044827ae1c425
Autor:
Lea S. Blaser, Alexandra E. Rätz Bravo, Sarah Hofmann, Andreas Holbro, Manuel Haschke, Stephan Krähenbühl, Hala Hassna, Anne B. Taegtmeyer, Andreas Zeller
Publikováno v:
Blaser, Lea; Hassna, Hala; Hofmann, Sarah; Holbro, Andreas; Haschke, Manuel Martin; Rätz Bravo, Alexandra; Zeller, Andreas; Krähenbühl, Stephan; Taegtmeyer, Anne (2017). Leucopenia associated with metamizole: a case-control study. Swiss medical weekly, 147, w14438. EMH Schweizerischer Ärzteverlag 10.4414/smw.2017.14438
AIMS OF THE STUDY The aim of this study was to identify possible risk factors for the development of leucopenia associated with metamizole use. METHODS A retrospective case-control study was performed. Cases of metamizole-associated leucopenia manage
Autor:
Anne B Taegtmeyer, Ivanka Curkovic, Natascia Corti, Christoph Rosen, Marco Egbring, Stefan Russmann, Andreas R Gantenbein, Michael Weller, Gerd A Kullak-Ublick
Publikováno v:
Swiss Medical Weekly, Vol 142, Iss 2728 (2012)
QUESTIONS UNDER STUDY/PRINCIPLES: Data regarding the prevalence and types of drug-related problems (DRPs) among neurology inpatients is sparse. The objective of this study was to characterise the types of DRPs seen among neurology inpatients and furt
Externí odkaz:
https://doaj.org/article/70ccbd4bc8fd492d8908822762640e4f
Publikováno v:
Swiss Medical Weekly, Vol 142, Iss 2930 (2012)
Roflumilast is a selective phosphodiesterase 4 inhibitor which has been licensed in the European Union since 2010 and in Switzerland since November 2011 as an add-on treatment for patients with chronic obstructive pulmonary disease (COPD) in GOLD (Gl
Externí odkaz:
https://doaj.org/article/986849c2365f457fae4c730c4b2f51e3
Publikováno v:
Therapeutische Umschau. 73:315-319
Zusammenfassung. Die Zunahme der Multimorbidität in der Bevölkerung führt dazu, dass auch die Anzahl an Patienten mit einer Polymedikation wächst. Es ist wichtig zwischen «angemessener» und «problematischer» Polymedikation zu unterscheiden. I